We are live on ! Find out more
PHIO icon

Phio Pharmaceuticals
PHIO

1 hedge funds and large institutions have $4.98M invested in Phio Pharmaceuticals in 2014 Q2 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

28% less capital invested

Capital invested by funds: $6.95M → $4.98M (-$1.97M)

50% less funds holding

Funds holding: 2 → 1 (-1)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Holders
1
Holders Change
-1
Holders Change %
-50%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
NI
Numeric Investors
Massachusetts
-$1.4M
2
TCM
Tang Capital Management
California
-$78K
3
Citadel Advisors
Citadel Advisors
Florida
-$53K
4
Goldman Sachs
Goldman Sachs
New York
-$45K
5
U
UBS
Switzerland
-$21K
Name Holding Trade Value Shares
Change 		Change in
Stake
BC
1
Broadfin Capital
New York
$3.4M – – –
SFM
2
Sphera Funds Management
Israel
$531K – – –
CS
3
Credit Suisse
Switzerland
$267K – – –
Jane Street
4
Jane Street
New York
$188K – – –
Vanguard Group
5
Vanguard Group
Pennsylvania
$186K – – –
VKH
6
Virtu KCG Holdings
New York
$167K – – –
Geode Capital Management
7
Geode Capital Management
Massachusetts
$76K – – –
Northern Trust
8
Northern Trust
Illinois
$47K – – –
Bank of America
9
Bank of America
North Carolina
$42K – – –
SIM
10
Spark Investment Management
New York
$33K – – –
TDC
11
Thompson Davis & Co
Virginia
$9K – – –
Barclays
12
Barclays
United Kingdom
$8K – – –
BIM
13
BlackRock Investment Management
Delaware
$6K – – –
TRCT
14
Tower Research Capital (TRC)
New York
$5K – – –
Morgan Stanley
15
Morgan Stanley
New York
$4K – – –
Group One Trading
16
Group One Trading
Illinois
$2K – – –
GSC
17
Ground Swell Capital
South Carolina
$1K – – –
LTFS
18
Ladenburg Thalmann Financial Services
Florida
$1K – – –
AIG
19
American International Group
New York
$33 – – –
NI
20
Numeric Investors
Massachusetts
– -$1.4M -1 Closed
Citadel Advisors
21
Citadel Advisors
Florida
– -$53K – –
Goldman Sachs
22
Goldman Sachs
New York
– -$45K – –
TCM
23
Tang Capital Management
California
– -$78K – –
U
24
UBS
Switzerland
– -$21K – –

PHIO Hedge Fund Activity: Q2 2014 in Review

1 of the 3,480 institutional investors tracked by Wall St. Rank reported a position in Phio Pharmaceuticals (PHIO) for Q2 2014, worth a combined $4.98M — down 28% from $6.95M a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of PHIO and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.

The largest seller was Numeric Investors, exiting entirely with an estimated $1.4M sold.

  • 1 institutional investor held Phio Pharmaceuticals (PHIO) as of Q2 2014, down from 2 in Q1 2014.
  • Funds reported $4.98M of Phio Pharmaceuticals stock for Q2 2014, down 28% quarter-over-quarter.
  • 0 funds opened new Phio Pharmaceuticals positions in Q2 2014 and 1 closed out, a net change of -1 holder.
  • The largest Phio Pharmaceuticals seller in Q2 2014 was Numeric Investors, an estimated $1.4M sold.

Based on aggregated 13F filings for Q2 2014.